Diazepam and Emgality drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Diazepam (diazepam) and Emgality (galcanezumab-gnlm). Common drug interactions include retching among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Diazepam and Emgality. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Diazepam?

Diazepam has active ingredients of diazepam. It is often used in stress and anxiety. eHealthMe is studying from 108,384 Diazepam users. Check the latest studies of Diazepam.

What is Emgality?

Emgality has active ingredients of galcanezumab-gnlm. eHealthMe is studying from 24,702 Emgality users. Check the latest studies of Emgality.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 27, 2026

78 people who take Diazepam and Emgality together, and have interactions are studied.

Diazepam and Emgality drug interactions.

What are the common drug interactions of Diazepam and Emgality, by gender? *:

female:

  1. Retching (strong involuntary effort to vomit)
  2. Skin disorder (skin disease)
  3. Snoring
  4. Suicide attempt
  5. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  6. Weight increased
  7. Asthenia (weakness)
  8. Chest pain
  9. Cystitis (inflammation of the wall of the bladder)
  10. Exostosis (formation of new bone on the surface of a bone)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Chronic kidney disease
  3. Back pain
  4. Cat scratch disease (bacterial infection by cat scratch)
  5. Coma (state of unconsciousness lasting more than six hours)
  6. Constipation
  7. Cyclic vomiting syndrome (prolonged episodes of severe nausea, vomiting)
  8. Drug ineffective
  9. Dyskinesia (abnormality or impairment of voluntary movement)
  10. Gamma-glutamyltransferase increased

What are the common drug interactions of Diazepam and Emgality, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Drug ineffective
  2. Hallucination, auditory (perceiving sounds without auditory stimulus)
  3. Screaming (a long loud piercing cry)
  4. Back pain
  5. Cat scratch disease (bacterial infection by cat scratch)
  6. Coma (state of unconsciousness lasting more than six hours)
  7. Constipation
  8. Cyclic vomiting syndrome (prolonged episodes of severe nausea, vomiting)
  9. Depression
  10. Dyskinesia (abnormality or impairment of voluntary movement)

30-39:

  1. Eye pain
  2. Injection site reaction
  3. Hysterectomy
  4. Initial insomnia (feeling of inadequate or poor-quality sleep)
  5. Injection site pruritus (severe itching at injection site)
  6. Insomnia (sleeplessness)
  7. Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
  8. Pericarditis (inflammation of the pericardium)
  9. Pruritus (severe itching of the skin)
  10. Rash pruritic (redness with itching)

40-49:

  1. Chronic kidney disease
  2. Fatigue (feeling of tiredness)
  3. Pneumonia
  4. Dyspnoea (difficult or laboured respiration)
  5. Injection site erythema (redness at injection site)
  6. Injection site pruritus (severe itching at injection site)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nausea (feeling of having an urge to vomit)
  9. Pain
  10. Pyrexia (fever)

50-59:

  1. Necrosis (the death of body tissue)
  2. Nerve injury
  3. Pain
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  6. Secondary progressive multiple sclerosis (a stage of ms which comes after relapsing remitting ms in many cases)
  7. Fatigue (feeling of tiredness)
  8. Asthma
  9. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  10. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)

60+:

  1. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  2. Headache (pain in head)
  3. Cardiac disorder
  4. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  5. Drug hypersensitivity
  6. Gait disturbance
  7. Gamma-glutamyltransferase increased
  8. Hospitalisation
  9. Joint stiffness
  10. Joint swelling

What are the existing conditions these people have? *

  1. Migraine (headache): 25 people, 32.05%
  2. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 16.67%
  3. Asthma: 10 people, 12.82%
  4. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 10 people, 12.82%
  5. Pain: 9 people, 11.54%
  6. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 8.97%
  7. Immunodeficiency Common Variable: 7 people, 8.97%
  8. Insomnia (sleeplessness): 7 people, 8.97%
  9. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 8.97%
  10. Nausea (feeling of having an urge to vomit): 7 people, 8.97%

* Approximation only. Some reports may have incomplete information.

Do you take Diazepam and Emgality?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Diazepam and Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Diazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Emgality:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Diazepam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Emgality and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diazepam and galcanezumab-gnlm (the active ingredients of Diazepam and Emgality, respectively), and Diazepam and Emgality (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: